| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2021 | Mar 8, 2021 | IGC Pharma, Inc. | CEO | Sell | 22.5 | -50,000 | -1.77% | ✗ | $107K |
| Jun 7, 2020 | Dec 2, 2020 | IGC Pharma, Inc. | CEO | Sell | 22.5 | -600,000 | -17.52% | ✗ | $187K |
| Aug 30, 2018 | Aug 31, 2018 | IGC Pharma, Inc. | CEO | Sell | 22.5 | -50,000 | -2.20% | ✗ | $93.3K |
| Aug 14, 2018 | Aug 29, 2018 | IGC Pharma, Inc. | CEO | Sell | 90.0 | +147,228 | 5.62% | ✗ | $207.1K |
| Jan 10, 2018 | Jan 12, 2018 | IGC Pharma, Inc. | CEO | Sell | 26.3 | -36,000 | -1.51% | ✗ | $39.2K |
| Dec 14, 2017 | Dec 18, 2017 | IGC Pharma, Inc. | CEO | Sell | 26.3 | -50,000 | -2.05% | ✗ | $37.8K |
| Dec 7, 2017 | Dec 8, 2017 | IGC Pharma, Inc. | CEO | Sell | 22.5 | -154,950 | -5.97% | ✗ | $132.9K |
| Oct 18, 2017 | Nov 3, 2017 | IGC Pharma, Inc. | CEO | Sell | 22.5 | -300,000 | -37.86% | ✗ | $135.3K |
| Jan 13, 2017 | Jan 17, 2017 | IGC Pharma, Inc. | CEO | Sell | 91.3 | +1,087,033 | 76.75% | ✗ | $19.1K |